Medicare Enrolled

Dr. Vinicius Costa Diniz Domingues, M.D.

Rheumatology · Daytona Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
709 N CLYDE MORRIS BLVD, Daytona Beach, FL 32114
3862521632
In practice since 2012 (13 years)
NPI: 1023364387 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Costa Diniz Domingues from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Costa Diniz Domingues? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Costa Diniz Domingues

Dr. Vinicius Costa Diniz Domingues is a rheumatology in Daytona Beach, FL, with 13 years in practice. Based on federal Medicare data, Dr. Costa Diniz Domingues performed 1,024,972 Medicare services across 1,418 unique beneficiaries.

Between the years covered by Open Payments, Dr. Costa Diniz Domingues received a total of $807,654 from 58 pharmaceutical and/or device companies across 1940 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Costa Diniz Domingues is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ Top 0% volume in FL$ $807,654 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,024,972
Medicare services
Top 0% in FL for rheumatology
1,418
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~78,844 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)983,800$4$13
Romosozumab injection (Evenity) for osteoporosis28,140$8$12
Denosumab injection (Prolia/Xgeva)6,300$18$35
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle5,158$56$189
Office visit, established patient (30-39 min)1,188$94$270
New patient office visit, complex (60-74 min)187$162$521
Steroid injection (triamcinolone)145$1$15
Joint injection, major joint29$50$175
Drug injection, under skin or into muscle25$10$64
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$807,654
Total received (2018-2024)
Avg $115,379/year across 7 years
Top 2% in FL for rheumatology
58
Companies
1,940
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$638,207 (79.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$155,687 (19.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,760 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$133,594
2023
$220,536
2022
$158,373
2021
$112,471
2020
$86,930
2019
$75,666
2018
$20,084

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$249,659
Horizon Therapeutics plc
$105,982
ABBVIE INC.
$91,064
GENZYME CORPORATION
$60,407
AbbVie Inc.
$59,603
GlaxoSmithKline, LLC.
$43,714
Aurinia Pharma U.S., Inc.
$37,988
UCB, Inc.
$32,987
AstraZeneca Pharmaceuticals LP
$29,626
Janssen Biotech, Inc.
$29,394
Amgen Inc.
$25,012
Novartis Pharmaceuticals Corporation
$9,225
Janssen Scientific Affairs, LLC
$6,280
Regeneron Pharmaceuticals, Inc.
$6,118
AbbVie, Inc.
$4,156
PFIZER INC.
$3,262
E.R. Squibb & Sons, L.L.C.
$2,416
Eli Lilly and Company
$2,389
Janssen Global Services, LLC
$2,000
UCB SA
$920
Radius Health, Inc.
$806
Boehringer Ingelheim Pharmaceuticals, Inc.
$667
Octapharma USA, Inc.
$628
Celgene Corporation
$423
Horizon Pharma plc
$360
SANOFI-AVENTIS U.S. LLC
$329
Regeneron Healthcare Solutions, Inc.
$261
Genentech USA, Inc.
$251
Mallinckrodt Hospital Products Inc.
$224
Mallinckrodt LLC
$201
Mallinckrodt Enterprises LLC
$168
Takeda Pharmaceuticals U.S.A., Inc.
$130
Genentech, Inc.
$102
Alexion Pharmaceuticals, Inc.
$99
Sobi, Inc
$87
kaleo, Inc.
$72
CSL Behring
$68
Pharming Healthcare, Inc.
$59
Grifols USA, LLC
$47
Sandoz Inc.
$44
Antares Pharma, Inc.
$42
Organon Llc
$40
Hikma Pharmaceuticals USA
$35
Eyevance Pharmaceuticals LLC
$35
SCILEX PHARMACEUTICALS INC.
$35
Kiniksa Pharmaceuticals International, plc
$28
Celltrion USA Inc.
$28
SOBI, INC
$28
Merck Sharp & Dohme Corporation
$18
Bioventus LLC
$18
ANI Pharmaceuticals, Inc.
$17
Actelion Pharmaceuticals US, Inc.
$17
Shire North American Group Inc
$16
Merck Sharp & Dohme LLC
$16
MEDAC PHARMA, INC.
$15
MEDEXUS PHARMA, INC.
$13
Ultragenyx Pharmaceutical Inc.
$12
Phadia US Inc.
$12
Top 3 companies account for 55.3% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AUVI-Q · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CUTAQUIG · CUVITRU · CYLTEZO · Cimzia · DUPIXENT · Durolane · EVENITY · EVUSHELD · Enbrel · FASENRA · FORTEO · GAZYVA · HADLIMA · HUMIRA · HYQVIA · HYRIMOZ · Hizentra · Humira · INFLECTRA · ImmunoCAP · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · ORENCIA · OTREXUP · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · RUCONEST · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tobradex ST · Tymlos · XELJANZ · XYOSTED · Xembify · YUFLYMA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for rheumatology in FL.

Equivalent to $79 per 100 Medicare services performed
Looking for a rheumatology in Daytona Beach?
Compare rheumatologys in the Daytona Beach area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
7
Per 100K population
1.2
County median income
$66,581
Nearest hospital
HALIFAX HEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Costa Diniz Domingues is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (speaking/promotional, top 2%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Costa Diniz Domingues experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Costa Diniz Domingues performed 983,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Costa Diniz Domingues receive payments from pharmaceutical companies?
Yes. Dr. Costa Diniz Domingues received a total of $807,654 from 58 companies across 1,940 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Costa Diniz Domingues's costs compare to other rheumatologys in Daytona Beach?
Dr. Costa Diniz Domingues's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Costa Diniz Domingues) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →